Sort
23,748 grants matching “melanoma”
Recognition of Self and Mutated Self by Autoimmune and Tumor-Specific TCRs
$384,690Roy A Mariuzza · Univ Of Maryland, College Park · R01 · FY2011 · AI
Recognition of Self and Mutated Self by Autoimmune and Tumor-Specific TCRs
$384,690Roy A Mariuzza · Univ Of Maryland, College Park · R01 · FY2012 · AI
Integration of neo-antigen vaccines and immune checkpoint therapy
$384,650Elizabeth Marion Jaffee · Johns Hopkins University · P01 · FY2022 · CA
Therapeutic resistance and tumor heterogeneity in BRAF mutant colorectal cancer
$384,605Ryan Bruce Corcoran · Massachusetts General Hospital · R01 · FY2019 · CA
Metal Organic Frameworks-Based Next-Generation Sunscreens for Cancer Prevention
$384,570R. Osman K. Ozdemir · Framergy, Inc. · R43 · FY2020 · CA
Follicular Regulatory T-cells Promote Cancer
$384,562Jianmei Wu Leavenworth · University Of Alabama At Birmingham · R01 · FY2025 · CA
Transcriptional and epigenetic mechanisms of immunotherapy resistance in melanoma
$384,559Kai W Wucherpfennig · Massachusetts General Hospital · P01 · FY2019 · CA
Lymphatic Imaging
$384,524Peter L. Choyke · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Statistical Methods for Population Genomics and "Next-gen" Sequencing Data
$384,477Paul A Scheet · University Of Tx Md Anderson Can Ctr · R01 · FY2012 · HG
Biogenesis of Melanosomes
$384,475New York University School Of Medicine · R01 · FY2005 · AR
Biogenesis of Melanosomes
$384,475New York University School Of Medicine · R01 · FY2004 · AR
Generation and utility of NADPH oxidase inhibitors
$384,435Sara A Courtneidge · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2012 · CA
Targeting apoptosis via chemical design of Bcl-2 antagonists
$384,435Maurizio Pellecchia · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2012 · CA
Generation and utility of NADPH oxidase inhibitors
$384,435Sara A Courtneidge · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2011 · CA
Targeting apoptosis via chemical design of Bcl-2 antagonists
$384,435Maurizio Pellecchia · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2011 · CA
Characterization of JNK in Cell Cycle Control
$384,435Ze'ev A Ronai · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2011 · CA
EXPERIMENTAL TRANSFORMATION OF HUMAN MELANOCYTES IN VIVO
$384,401Wistar Institute · R01 · FY2003 · CA
Regulation of the ERK signaling pathway by K63-linked polyubiquitination
$384,394Xiaolu Yang · University Of Pennsylvania · R01 · FY2024 · CA
Studying the initiation, progression and therapy of lung cancer in mouse models
$384,375Martin McMahon · University Of Utah · R01 · FY2023 · CA
Molecular Targeted Radionuclide Therapy to Enhance Tumor Cell Susceptibility and Response to Immune Checkpoint Inhibition
$384,278Zachary Scott Morris · University Of Wisconsin-Madison · P01 · FY2022 · CA
Molecular Targeted Radionuclide Therapy to Enhance Tumor Cell Susceptibility and Response to Immune Checkpoint Inhibition
$384,278Zachary Scott Morris · University Of Wisconsin-Madison · P01 · FY2023 · CA
PD-1/PD-L1 signaling at the interface between immune and stem cell crosstalk
$384,250Melissa L Harris · University Of Alabama At Birmingham · R56 · FY2025 · AI
Actively engaging NK cells during virotherapy to induce neoantigen-specific antitumor immunity
$384,242Xiaoliu Zhang · University Of Houston · R01 · FY2022 · CA
Actively engaging NK cells during virotherapy to induce neoantigen-specific antitumor immunity
$384,242Xiaoliu Zhang · University Of Houston · R01 · FY2025 · CA
Molecular Mechanisms Of Synaptic Transmission
$384,223David Robinson · National Institute On Deafness And Other Communication Disorders · ZIA · FY2012 · DC